Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FOLD | AZN | AMGN | GILD | BMY |
| Company | Amicus Therapeutics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 14.45 | 202.77 | 348.51 | 138.50 | 58.34 |
| High | 14.45 | 202.77 | 348.51 | 138.50 | 58.34 |
| Low | 14.45 | 202.77 | 348.51 | 138.50 | 58.34 |
| Latest | 14.45 | 202.17 | 349.52 | 138.67 | 58.50 |
| Change | -0.01 | -1.86 | -1.50 | -0.32 | -0.12 |
| % Change | -0.07% | -0.91% | -0.43% | -0.23% | -0.20% |
| Volume | 1,068 | 15,730 | 853 | 1,097 | 10,457 |
| 20-Day Average Volume | 3,227,223 | 1,794,501 | 2,668,228 | 5,686,400 | 12,890,998 |
| Previous Close | 14.46 | 204.03 | 351.02 | 138.99 | 58.62 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.43 | 194.40 | 351.01 | 139.49 | 59.00 |
| 20-Day Raw Stochastic | 76.36% | 81.81% | 37.54% | 35.96% | 32.76% |
| 20-Day Relative Strength | 70.14 | 57.62 | 45.66 | 46.31 | 47.89 |
| Weighted Alpha | +94.34 | +48.98 | +24.52 | +31.28 | +23.06 |
| Today's Opinion | 100% Buy | 88% Buy | 40% Buy | 40% Buy | 48% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 40% Buy | 40% Buy | 48% Buy |
| Last Month's Opinion | 100% Buy | 56% Buy | 88% Buy | 88% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 04/06/26 | -0.03% since 04/06/26 | +1.73% since 04/06/26 | -1.16% since 04/06/26 | -1.67% since 04/06/26 |
| Low | 14.45 on 04/10/26 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 14.48 on 04/08/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 59.80 on 04/10/26 |
| 1-Month | |||||
| %Chg | +0.58% since 03/13/26 | +6.78% since 03/13/26 | -4.83% since 03/13/26 | -4.48% since 03/13/26 | -1.25% since 03/13/26 |
| Low | 14.37 on 03/20/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 14.48 on 04/08/26 | 207.30 on 04/10/26 | 370.89 on 03/16/26 | 146.71 on 03/17/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +0.94% since 01/13/26 | +7.27% since 01/13/26 | +7.47% since 01/13/26 | +13.75% since 01/13/26 | +4.33% since 01/13/26 |
| Low | 14.26 on 02/06/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 53.54 on 01/21/26 |
| High | 14.48 on 04/08/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +76.70% since 10/13/25 | +19.97% since 10/13/25 | +19.19% since 10/13/25 | +17.16% since 10/13/25 | +34.00% since 10/13/25 |
| Low | 7.87 on 10/17/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 14.48 on 04/08/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,540,455 | 316,431,744 | 189,440,224 | 172,517,456 | 119,686,496 |
| Shares Outstanding, K | 314,001 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 634,210,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -27,110,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 185,210,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 1,690,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.48 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.10 on 02/20/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/07/26 | 05/05/26 | 04/30/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 482.33 | 22.38 | 16.27 | 17.43 | 9.67 |